Some streptococcal and staphylococcal species are capable of producing circulating toxins. Patients infected with these toxin-producing bacteria exhibit clinical manifestations distant from the site of local infection. Several distinct syndromes related to these toxins have been recognized, including toxic shock syndrome (TSS) and staphylococcal scalded skin syndrome (SSSS).
The responsible toxins act as superantigens, bypassing the normal sequence of immune system activation to stimulate an immune response in a general, nonspecific manner. This nonspecific immunologic activation leads to damage in various organ systems.
Both toxic shock syndrome and staphylococcal scalded skin syndrome have characteristic cutaneous features that will be discussed next.
Clinical Manifestations
TSS is the constellation of fever, rash, hypotension, and multisystem organ involvement (at least three organ systems) and its presentation ranges from mild to fatal disease.
TSS typically presents with the sudden onset of high fever, muscle aches, vomiting, diarrhea, and headache.
A diffuse macular erythema or a scarlatiniform (i.e., sandpaper-like feel) exanthem with accentuation in flexures develops first on the trunk and quickly spreads to the extremities.
Other skin features that may be present include erythema and edema of the palms and soles, hyperemia of the conjunctiva and mucous membranes, and strawberry tongue.
Desquamation of the palms and soles may occur 1 to 3 weeks after the onset of illness (Fig. 7.21).
Diagnosis
Diagnosis is made when the characteristic clinical findings of fever, rash, and hypotension are present in patients who have an infection with S. aureus or Strepococcus.
Blood urea nitrogen, creatinine, liver enzymes, and the white blood cell count may be elevated and thrombocytopenia may be present.
Gram stain and cultures of vaginal exudate or wounds positive for S. aureus or, rarely, group A streptococci can support the diagnosis.
Kawasaki Syndrome (see Chapter 10: Cutaneous Manifestations of Systemic Disease) |
|
Pathogenesis
The exfoliative toxin derived from S. aureus spreads from the initial site of infection, usually the nasopharyx or conjunctiva, via the bloodstream.
The toxin is epidermolytic and cleaves desmoglien 1, an important protein necessary for cell-to-cell adhesion in the granular layer of the epidermis, resulting in blister formation.
Clinical Features
The prodrome consists of fever, irritability, and skin pain.
Sometimes evidence of the staphylococcal infection in the conjunctiva or nose may be present as conjunctivitis or rhinorrhea.
The skin eruption begins as diffuse redness of the skin starting on the head and neck (with or without facial swelling) and flexures and becomes generalized over 1 to 2 days (Fig. 7.22).
Soon thereafter, flaccid bullae develop that easily rupture with minimal pressure leaving behind moist superficial erosions (Fig. 7.23).
Nikolsky sign, the easy separation of epidermis with minimal lateral pressure, is positive.
Periorificial crusting and radial fissuring with sparing of the oral mucosa is a characteristic clinical feature.
Desquamation can last 3 to 5 days, followed by complete healing without scarring.
Diagnosis
Cultures taken from the bullae and erosions on the skin are negative but S. aureus may be cultured from the conjunctiva, nasopharynx, or perianal skin.
|